Detalhe da pesquisa
1.
Chemistry-First Approach for Nomination of Personalized Treatment in Lung Cancer.
Cell
; 173(4): 864-878.e29, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29681454
2.
Systematic identification of molecular subtype-selective vulnerabilities in non-small-cell lung cancer.
Cell
; 155(3): 552-66, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24243015
3.
Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancer.
Genes Dev
; 30(11): 1289-99, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27298335
4.
Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis.
Int J Mol Sci
; 24(1)2022 Dec 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36614027
5.
A Bayesian hidden Potts mixture model for analyzing lung cancer pathology images.
Biostatistics
; 20(4): 565-581, 2019 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29788035
6.
Integrative gene set enrichment analysis utilizing isoform-specific expression.
Genet Epidemiol
; 41(6): 498-510, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28580727
7.
Meta-analysis approaches to combine multiple gene set enrichment studies.
Stat Med
; 37(4): 659-672, 2018 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29052247
8.
Genome-wide copy number variation pattern analysis and a classification signature for non-small cell lung cancer.
Genes Chromosomes Cancer
; 56(7): 559-569, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28379620
9.
A statistical method for detecting differentially expressed SNVs based on next-generation RNA-seq data.
Biometrics
; 73(1): 42-51, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276420
10.
ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
Proc Natl Acad Sci U S A
; 111(41): 14788-93, 2014 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267614
11.
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpression.
Mol Syst Biol
; 11(12): 842, 2015 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26655797
12.
A small-cell lung cancer genome with complex signatures of tobacco exposure.
Nature
; 463(7278): 184-90, 2010 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-20016488
13.
High-throughput oncogene mutation profiling in human cancer.
Nat Genet
; 39(3): 347-51, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17293865
14.
Microtubule affinity-regulating kinase 2 is associated with DNA damage response and cisplatin resistance in non-small cell lung cancer.
Int J Cancer
; 137(9): 2072-82, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25907283
15.
Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Genome Res
; 22(7): 1197-211, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22613842
16.
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.
Genome Res
; 22(12): 2315-27, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23033341
17.
Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.
Proteomics
; 14(23-24): 2750-9, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25331784
18.
Analysis of TP53 mutation status in human cancer cell lines: a reassessment.
Hum Mutat
; 35(6): 756-65, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24700732
19.
HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors.
Cancer Cell
; 10(1): 25-38, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16843263
20.
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer.
Cancer Cell
; 10(1): 39-50, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16843264